Rhabdomyosarcoma Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com

Share Article

RnRMarketResearch.com adds “Rhabdomyosarcoma – Pipeline Review, H1 2015” to its store. The report provides an overview of the Rhabdomyosarcoma’s therapeutic pipeline.

Rhabdomyosarcoma Therapeutic Pipeline Review H1 2015

Rhabdomyosarcoma Therapeutic Pipeline Review H1 2015

Past News Releases

RSS

The report “Rhabdomyosarcoma – Pipeline Review, H1 2015” provides comparative analysis on the therapeutic development for Rhabdomyosarcoma. The report strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Complete report with TOC is available @ http://www.rnrmarketresearch.com/rhabdomyosarcoma-pipeline-review-h1-2015-market-report.html.

The report also reviews key players involved in the therapeutic development for Rhabdomyosarcoma and special features on late-stage and discontinued projects. Companies discussed in this Rhabdomyosarcoma – Pipeline Review, H1 2015 report include Bellicum Pharmaceuticals, Inc., Boehringer Ingelheim GmbH, Celgene Corporation, Eisai Co., Ltd., GlaxoSmithKline plc, Merrimack Pharmaceuticals, Inc., Neotropix, Inc. and Novartis AG.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Drug Profiles mentioned in this report are afatinib, Cell Therapy for GD2 Expressing Solid Tumors, celyvir, Dendritic Cell Therapy to Target MAGE-A1, MAGE-A3 and NY-ESO-1 for Oncology, E-7438, everolimus, irinotecan sucrosofate liposomal, NTX-010, paclitaxel albumin bound and pazopanib hydrochloride.

Order a purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=365319 . (This is a premium report priced at US$2000 for a single user License.)

List of Tables
Number of Products under Development for Rhabdomyosarcoma, H1 2015 7
Number of Products under Development for Rhabdomyosarcoma - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Number of Products under Investigation by Universities/Institutes, H1 2015 10
Comparative Analysis by Clinical Stage Development, H1 2015 11
Products under Development by Companies, H1 2015 12
Products under Investigation by Universities/Institutes, H1 2015 13
Rhabdomyosarcoma - Pipeline by Bellicum Pharmaceuticals, Inc., H1 2015 14
Rhabdomyosarcoma - Pipeline by Boehringer Ingelheim GmbH, H1 2015 15
Rhabdomyosarcoma - Pipeline by Celgene Corporation, H1 2015 16
Rhabdomyosarcoma - Pipeline by Eisai Co., Ltd., H1 2015 17
Rhabdomyosarcoma - Pipeline by GlaxoSmithKline plc, H1 2015 18
Rhabdomyosarcoma - Pipeline by Merrimack Pharmaceuticals, Inc., H1 2015 19
Rhabdomyosarcoma - Pipeline by Neotropix, Inc., H1 2015 20
Rhabdomyosarcoma - Pipeline by Novartis AG, H1 2015 21
Assessment by Monotherapy Products, H1 2015 22
Number of Products by Stage and Target, H1 2015 24
Number of Products by Stage and Mechanism of Action, H1 2015 26
Number of Products by Stage and Route of Administration, H1 2015 28
Number of Products by Stage and Molecule Type, H1 2015 30
Rhabdomyosarcoma Therapeutics - Recent Pipeline Updates, H1 2015 58
Rhabdomyosarcoma - Dormant Projects, H1 2015 84
Rhabdomyosarcoma - Discontinued Products, H1 2015 85

List of Figures
Number of Products under Development for Rhabdomyosarcoma, H1 2015 7
Number of Products under Development for Rhabdomyosarcoma - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Comparative Analysis by Clinical Stage Development, H1 2015 11
Assessment by Monotherapy Products, H1 2015 22
Number of Products by Top 10 Targets, H1 2015 23
Number of Products by Stage and Top 10 Targets, H1 2015 23
Number of Products by Top 10 Mechanism of Actions, H1 2015 25
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 25
Number of Products by Top 10 Routes of Administration, H1 2015 27
Number of Products by Stage and Top 10 Routes of Administration, H1 2015 28
Number of Products by Top 10 Molecule Types, H1 2015 29
Number of Products by Stage and Top 10 Molecule Types, H1 2015 30

Explore more reports on Cancer Therapeutics industry at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/cancer-therapeutics .

About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ritesh Tiwari
@RnRMR
since: 06/2012
Follow >
RnR Market Research
Like >
Follow us on
Visit website